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Going forward together: cooperative invasion in
melanoma
Sonia Wojciechowska and E. Elizabeth Patton
e-mail: e.patton@igmm.ed.ac.uk
Early-stage melanomas can be excised
by surgery, but once they have begun
to invade and metastasize, treatment
requires additional therapeutic interven-
tions. Thus, understanding the mecha-
nisms that drive tumor invasion and
metastasis is critical for drug develop-
ment, and to prevent the spread of dis-
ease. In a recent study from the
Wellbrock and Hurlstone laboratories,
melanoma cells with less invasive
potential are shown to become invasive
with the help of other tumor cells, dem-
onstrating that melanoma cells can
work together to promote malignancy
(Chapman et al., 2014). These interac-
tions may be important drug targets.
One of the most enticing features of
the zebrafish system for cancer biology
is live in vivo imaging (White et al.,
2013). Zebrafish embryos are optically
transparent, enabling fluorescent repor-
ter lines to reveal tissue development
and cellular movements in amazing
detail. Zebrafish are fertilized outside
the mother, so that embryos can be
imaged from the single cell stage
through to adulthood. As vertebrates
that share over 70% of the genome
with humans, zebrafish develop cancers
with many of the pathological features
as humans. In addition, zebrafish are
amenable to (xeno) transplantation, so
that the fundamental aspects of cancer
cell biology can be visualized in living
animals. Their small size (10 embryos
can easily fit into a well of a 24-well
plate in 1 ml of solution) means that
this is an ideal system to screen and
test new compounds. Already, drug
activity identified through zebrafish
small molecule screens are in clinical
trial, including leflunomide for the treat-
ment of melanoma (NCT01611675).
Malignant melanoma is comprised of
different tumor cell subpopulations, but
how these subpopulations relate to
each other and contribute to cancer pro-
gression is not well understood. Multi-
cellular imaging in cancers has revealed
networks of paracrine interactions that
contribute to heterogeneity and collec-
tive cell movements (Calvo and Sahai,
2011). In fact, some of the first evi-
dence for cooperative interactions in
melanoma was shown in primary mela-
noma explants whereby differential
adhesion to matrix-enabled collective
migration (Hegerfeldt et al., 2002). In a
new study by Chapman et al. (2014),
they take advantage of a zebrafish-mel-
anoma xenograft model to show that
heterogeneous tumor cell subpopula-
tions can interact with each other to
contribute to tumor progression via
cooperative invasion. To examine the
potential importance of melanoma het-
erogeneity, Chapman et al. used two
melanoma cell lines, both with the com-
mon BRAFV600E mutation, but with dif-
ferent invasive potentials (WM266-4
highly invasive; 501mel poorly invasive;
both derived from human metastatic
melanoma). Zebrafish embryos were
injected in the pericardium with either
WM266-4 cells, 501mel cells or with an
equal ratio of both cell types. In all
cases, the melanoma cells formed
tumorlike masses. Some cells could be
imaged migrating away from the peri-
cardium tumor mass in filelike patterns.
Consistent with findings in other assay
systems, WM266-4 cells displayed high
invasiveness, whereas 501mel cells did
not invade. The surprise came in the
case of heterogeneous xenografts,
where the invasion potential of 501mel
cells increased to levels similar to that
of WM266-4 cells. This indicates that
poorly invading melanoma cells can
alter their behavior to actively invading
when interacting with other cells in a
heterogeneous environment.
While the invasion potential of
501mel cells could be stimulated by the
WM266-4 cells, closer examination
revealed that most of the time WM266-
4 cells were leading the files of cells. It
is well known that degradation of the
extracellular matrix (ECM) by matrix me-
talloproteases is an important feature of
cancer invasion. Indeed, the authors
discover that WM266-4 cells express
significantly higher levels of MMPs than
501mel cells. To test the involvement
of the proteolytic degradation of ECM
in cooperative invasion, the team
immersed the xenografted larvae in
water with protease inhibitors. This had
no effect on homogenous xenografts of
either 501mel cells (in which there is no
invasion in any case) or WM266-4 cells
(these cells continue to invade). In het-
erogeneous xenografts, however, the
inhibition caused a block of invasion in
501mel cells and a significant decrease
in invasion in WM266-4 cells. Support-
ing these findings, they then depleted
the expression of a major regulator of
protease-driven invasion, MT1-MMP, in
WM266-4 cells, resulting again in the
suppression of cooperative invasion, but
not affecting the invasion of homoge-
nous WM266-4 cells. Thus, MMPs are
critical for invasion of both cell types in
the context of heterogenous xeno-
grafts, but not in the context of homog-
enous WM266-4 cells alone.
The authors
hypothesize that
501mel cells
secrete a factor
that inhibits the
proteolytic-inde-
pendent inva-
siveness of
WM266-4 cells.
Chapman et al.
use a system
with WM266-4
spheroid cells embedded in collagen
and cocultured with either 501mel or
autologous cells in transwells, so that
they are physically separated each
other. They find that the exposure to
the 501mel cells modulates the
WM266-4 cell response to protease
inhibitors: WM266-4 cells shift from a
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predominantly rounded into an elon-
gated mode of invasion characteristic of
protease-dependent migration, indicat-
ing that a diffusible factor derived from
501mels can directly act upon WM266-
4 cells.
MMPs and ECM deposition can be
closely coupled in cancers, and the
authors show that homogenous xeno-
grafts of WM266-4, but not 501mel
cells, are surrounded by ECM proteins
collagen I and fibronectin. In heteroge-
neous xenografts, however, ECM pro-
teins are both present and even more
abundant than in WM266-4 xenografts
alone. Moreover, the majority of both
WM266-4 and 501mel invading cells
were found along the fibronectin and
collagen tracks. These ECM compo-
nents appear to be in flux, and treat-
ment with protease inhibitors leads to
increasing amounts of ECM. Finally,
the authors generate WM266-4 cells
with low levels of fibronectin by siRNA
and show that WB266-4-derived fibro-
nectin is essential for cooperative inva-
sion. The authors conclude that it is
the WM266-4 cells that are generating
the ECM and that a soluble factor
secreted by the 501mel cells stimu-
lates the production and dependence
on MMP–ECM proteins for WM266-4
cell invasion.
Many questions now remain to be
addressed, including how cooperative
invasion compares with collective cell
cancer invasion described within invad-
ing tumors (Calvo and Sahai, 2011;
Friedl et al., 2012; Hegerfeldt et al.,
2002). It remains to be tested if the
cooperative behaviors observed here
are reflections of those observed in col-
lective cell migrations and if this is hap-
pening within a tumor in vivo (e.g., as
described in Hegerfeldt et al., 2002).
Given the heterogeneity within cancers
(and cancer cell lines), it may be possi-
ble to identify leaders and followers
within a single cancer that demonstrate
similar behaviors. While the authors dili-
gently test another two cell lines and
observe generally similar behaviors, it is
not clear how broadly applicable this is
to other cells lines, or even between
matched cell lines derived from the
same cancer at different stages of can-
cer progression. Are there combinations
of cells that do not cooperate, and what
are the consequences of heterogenous
xenografts with cells of similar pheno-
types? An important step will be to
determine markers of the different cell
types that contribute to cooperative
invasion (it does not seem to be MITF
expression). Mechanistically, future
work should address the very interest-
ing questions of how non-invasive cells
cause invasive cells to lose their inva-
sive non-protease-dependent activity,
and why fibronectin deposition impairs
cooperative movement in the presence
of MMP inhibition but supports invasion
without MMP inhibition. Finally, with a
wide range of transgenic reporter lines
in zebrafish, the authors are now well
poised to address the role of host-
derived factors, such as fibroblasts,
macrophages, and neutrophils, in coop-
erative invasion.
One of the most important findings is
that the cooperative cross talk between
cells is targetable. If indeed, this pro-
cess is important in vivo, the authors
have a powerful in vivo zebrafish assay
to screen for drugs and drug-leads that
can target this activity, and to capture
the live imaging of the cell behaviors in
a whole animal context. As proof-
of-principle, the authors have already
shown that protease inhibitors can inhi-
bit cooperative invasion. Given the dan-
gerously high-invasive and migratory
behaviors of melanoma, it is important
to have new targetable processes for
this disease.
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